viral
genet
variant
wide
known
influenc
diseas
progress
among
infect
human
given
recent
rapid
emerg
pandem
infect
caus
diseas
viral
protein
variant
attract
research
interest
howev
littl
yet
written
genet
risk
factor
among
human
host
human
genet
variat
proven
affect
diseas
progress
outcom
import
diseas
hiv
infect
malaria
infest
fact
human
protein
encod
x
chromosom
mean
male
carri
rare
code
variant
express
variant
cell
wherea
femal
typic
express
variant
mosaic
distribut
determin
earli
xinactiv
event
sexbas
differ
express
uniqu
implic
epidemiolog
studi
design
assess
host
genet
factor
influenc
progress
asymptomat
infect
present
theoret
model
rare
code
variant
document
occur
natur
sever
human
superpopul
subpopul
show
rare
variant
predict
affect
bind
spike
protein
exist
peopl
nonfinnish
european
male
allel
found
higher
frequenc
femal
furthermor
class
missens
allel
predict
affect
bind
found
aggreg
among
ashkenazi
male
femal
respect
well
european
male
femal
outsid
finland
allel
rarer
popul
group
almost
absent
east
asian
genotyp
date
though
awar
full
genomewid
exomewid
sequenc
studi
may
ultim
requir
assess
human
genet
suscept
fulli
argu
basi
strong
prior
probabl
genotyp
class
allel
justifi
case
atyp
diseas
asymptomat
superspread
identifi
human
host
genet
variat
long
recogn
mitig
outcom
infest
malari
parasit
review
kariuki
william
human
protein
recent
shown
serv
bind
site
entri
human
cell
also
previous
shown
bind
sarscov
relat
viru
caus
seriou
respiratori
infect
human
earli
viral
spike
glycoprotein
protein
sarscov
bind
physic
peptidas
domain
use
receptor
bind
domain
rbd
therebi
enabl
viral
intern
note
gene
locat
xchromosom
human
male
hemizyg
gene
express
one
haplotyp
maternallyderiv
allel
femal
contrast
two
x
chromosom
gener
express
patern
matern
allel
mosaic
distribut
determin
earli
xinactiv
sinc
prior
knowledg
protein
bound
directli
viral
protein
sinc
prior
proteinprotein
interact
model
identifi
specif
amino
acid
residu
within
bound
directli
propos
code
variant
specif
site
like
genet
risk
factor
progress
infect
diseas
propos
risk
would
affect
human
male
femal
differ
method
gnomad
databas
human
genet
variat
catalogu
code
variant
adult
without
childhoodonset
neurodevelopment
syndrom
though
littl
phenotyp
detail
avail
particip
databas
serv
conveni
refer
background
human
genet
variat
access
entri
gnomad
databas
v
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
global
superpopul
eg
african
south
asian
repres
gnomad
specif
subpopul
eg
southern
european
avail
among
male
preval
rare
xlink
variant
equival
maf
allel
femal
preval
rare
link
variant
equival
twice
maf
allel
femal
two
x
chromosom
henc
twice
number
xlink
allel
retriev
cadd
score
download
version
cadd
phredscal
cadd
score
report
posit
allel
combin
also
use
onlin
tool
list
estim
deleteri
code
amino
acid
substitut
threedimension
model
use
molsoft
also
use
method
schapira
et
al
estim
chang
bind
energi
would
accru
naturallyoccur
missens
annot
intoler
plof
singlenucleotid
variant
snv
plof
tabl
rang
vari
x
chromosom
genotyp
success
x
chromosom
genotyp
success
variant
frequenc
supplementari
tabl
calcul
use
number
altern
allel
count
numer
number
chromosom
genotyp
success
locu
denomin
aggreg
allel
frequenc
variant
locat
bind
site
ie
exclud
bind
site
yield
frequenc
estim
roughli
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
male
per
femal
per
would
harbour
rare
allel
might
affect
bind
cell
express
importantli
rare
allel
distribut
evenli
across
human
subpopul
outlin
common
missens
singlenucleotid
polymorph
snp
predict
encod
uniprot
access
number
snp
observ
predict
interact
obviou
candid
site
particular
pathogen
interact
variou
superpopul
subpopul
gnomad
offer
differ
sampl
size
rare
xlink
variant
best
deconvolut
allel
frequenc
sex
subpopul
achiev
fuller
pictur
preval
hemizyg
male
individu
region
countri
diseas
risk
signal
confer
function
xlink
allel
otherwis
dilut
lump
hemizyg
male
heterozyg
femal
carrier
like
lower
risk
due
mosaic
express
variant
nextmostcommon
missens
variant
global
maf
predict
encod
model
predict
lie
immedi
besid
protein
interfac
albeit
lysin
side
chain
point
away
interfac
prior
work
bind
sarscov
recent
work
bind
other
identifi
three
main
protein
bind
domain
within
largest
includ
smallest
compris
last
includ
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
accord
li
et
al
residu
make
ridg
residu
make
loop
ridg
residu
make
loop
estim
high
prior
probabl
human
germlin
code
variant
affect
key
bind
residu
would
also
affect
affin
endogen
human
protein
viral
near
protein
interfac
variant
occur
natur
human
could
plausibl
affect
risk
progress
initi
encount
model
interfac
viral
spike
protein
shown
figur
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
consid
class
variant
group
estim
aggreg
preval
per
male
per
femal
rare
deleteri
xlink
allel
deplet
live
male
adult
observ
disproportion
among
heterozyg
carrier
femal
thu
observ
class
allel
twice
common
among
femal
male
may
reflect
degre
histor
select
allel
went
calcul
specif
frequenc
sex
vcf
file
download
gnomad
interfac
provid
breakdown
exom
genom
subpopul
sex
found
cadd
score
among
class
allel
rang
provid
score
interest
list
score
predict
deleteri
possibl
missens
allel
avail
http
offer
caveat
score
deleteri
difficult
interpret
context
base
specif
characterist
protein
abil
bind
coevolv
case
newlyevolv
partner
appli
method
schapira
et
al
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
measur
environment
exposur
typic
identifi
tag
snp
link
loci
small
effect
size
method
attend
complex
conserv
genomewid
threshold
requir
justifi
fact
previou
candidategen
studi
extrem
high
discoveri
rate
larg
due
use
conveni
sampl
gener
artefactu
signal
owe
popul
stratif
ie
fact
snp
allel
frequenc
vari
ancestr
popul
histor
reason
unrel
herit
risk
diseas
howev
given
truli
stagger
number
infect
rapid
progress
death
often
within
day
labourintens
geneagnost
method
unlik
yield
action
result
current
pandem
reason
argu
prior
knowledg
sarscov
biolog
emerg
knowledg
similar
sarscov
justifi
assess
variat
within
human
except
strong
candid
gene
host
respons
infect
fact
xlink
mean
rare
variant
enhanc
bind
vivo
would
like
increas
suscept
among
male
function
effect
possibl
also
exampl
femal
variant
carrier
might
shorter
asymptomat
period
like
develop
symptom
irrespect
viral
shed
statu
given
limit
number
code
variant
predict
affect
bind
spike
protein
variant
could
genotyp
rapidli
earlyonset
case
eg
paediatr
case
even
case
age
pilot
studi
unit
state
andor
european
countri
case
number
high
case
fatal
appear
high
rare
allel
like
found
deliveri
viral
nucleic
acid
test
affect
popul
urgent
need
given
mani
viral
sampl
alreadi
collect
addit
rapid
assay
target
snv
list
would
effici
mean
gather
data
test
hypothesi
notabl
test
rare
variant
burden
lose
power
rapidli
neutral
variant
variant
oppos
function
effect
group
togeth
restrict
variant
prior
evid
involv
spike
protein
bind
mani
missens
variant
gnomad
aggreg
crude
preval
rare
ie
exclud
common
missens
variant
gnomad
male
gnomad
femal
furthermor
among
patient
extrem
outcom
death
childhood
asymptomat
superspread
found
sequenc
entir
code
region
might
conceiv
identifi
ultrarar
privat
variant
catalogu
gnomad
enabl
assess
role
variant
convers
initi
infect
properlypow
genomewid
studi
correl
genet
variant
multipl
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
clinic
risk
factor
outcom
also
advis
realist
accomplish
near
term
procko
done
unbias
mutagenesi
region
bind
rbd
note
substitut
hydrophob
residu
eg
alanin
expect
increas
abil
aromat
residu
protein
pack
interfac
procko
protein
urgent
justifi
furthermor
given
recent
data
human
recombin
solubl
block
earli
stage
infect
naturallyoccur
human
variant
bound
tightli
viral
spike
protein
might
serv
better
decoy
viral
protein
would
candid
novel
molecul
therapeut
potenti
whether
studi
done
time
affect
patient
outcom
current
pandem
fact
three
pathogen
coronavirus
sarscov
merscov
emerg
past
two
decad
two
bind
enter
via
augur
addit
coronavirus
bind
like
emerg
futur
thu
knowledg
specif
hostpathogen
interact
molecular
level
import
time
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
